Bronchopulmonary Dysplasia
Bronchopulmonary Dysplasia (BPD) is a chronic lung disease commonly seen in premature infants, characterized by difficulty breathing and the need for oxygen support due to underdeveloped lungs.
Bronchopulmonary Dysplasia: Stem Cell Treatment for Preterm Infants
We are studying the safety of umbilical cord stem cells in preterm babies with bronchopulmonary dysplasia. This research aims to see if the treatment can help improve their lung health and overall development.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Is your newborn weighing 1250 grams or less?
- Was your newborn born at 28 weeks gestation or earlier?
- Is your newborn currently on ventilatory support?
- Does your newborn have any major health issues like severe heart problems or significant brain injury?
- Has your newborn had major surgery in the last 3 days?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Expanded Allogeneic Fetal Umbilical Cord Stem Mesenchymal Cells
Mesenchymal Cells
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Complexo Hospitalario Universitario A Coruna
Neonatology Department
A Coruña, Spain
Hospital Universitario La Paz
Neonatology Department
Chamartín, Spain
University Hospital Virgen Del Rocio S.L.
Neonatology Department
Huelva, Spain
Sponsor: Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.